ARID5A and neoplasm: Pan-cancer expression analysis revealed that ARID5A was significantly overexpressed in tumor tissues of GBM, KIRC, LAML, and PAAD, while it showed lower expression in tumor tissues of BLCA, BRCA, and CESC (Fig. 11A).